SA
IONS icon

SpiderRock Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

SpiderRock Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$482K Buy
12,036
+10
+0.1% +$465 0.01% 634
2024
Q2 		$573K Buy
+12,026
New +$493K 0.01% 529

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

SpiderRock Advisors's IONS Position: Q3 2024 in Review

SpiderRock Advisors increased its Ionis Pharmaceuticals (IONS) stake by 0.08% in Q3 2024, buying an estimated $465 and bringing the position to 12,036 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #634.

SpiderRock Advisors first reported a position in IONS in Q2 2024 and has held it in 2 quarters since. The position peaked at $573K in Q2 2024. 354 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

  • SpiderRock Advisors held 12,036 shares of Ionis Pharmaceuticals worth $482K as of Q3 2024.
  • SpiderRock Advisors bought 10 Ionis Pharmaceuticals shares in Q3 2024, an estimated $465.
  • Ionis Pharmaceuticals made up 0.01% of SpiderRock Advisors's portfolio in Q3 2024, its #634 holding.
  • SpiderRock Advisors first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • SpiderRock Advisors's Ionis Pharmaceuticals position peaked at $573K in Q2 2024.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.